430 related articles for article (PubMed ID: 25218489)
1. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization.
Tian B; Zhang L; Pan Z; Gou J; Zhang Y; Tang X
Int J Pharm; 2014 Nov; 475(1-2):385-92. PubMed ID: 25218489
[TBL] [Abstract][Full Text] [Related]
2. Effect of the third component on the aging and crystallization of cinnarizine-soluplus® binary solid dispersion.
Tian B; Ju X; Yang D; Kong Y; Tang X
Int J Pharm; 2020 Apr; 580():119240. PubMed ID: 32197983
[TBL] [Abstract][Full Text] [Related]
3. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
4. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
5. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
6. Theoretical prediction of a phase diagram for solid dispersions.
Tian B; Wang X; Zhang Y; Zhang K; Zhang Y; Tang X
Pharm Res; 2015 Mar; 32(3):840-51. PubMed ID: 25163982
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
8. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
[TBL] [Abstract][Full Text] [Related]
9. Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.
Li X; Jiang C; Pan L; Zhang H; Hu L; Li T; Yang X
Drug Dev Ind Pharm; 2015 Jan; 41(1):2-14. PubMed ID: 25026247
[TBL] [Abstract][Full Text] [Related]
10. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
11. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
12. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
15. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
16. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
[TBL] [Abstract][Full Text] [Related]
17. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
18. Effect of storage conditions on the recrystallization of drugs in solid dispersions with crospovidone.
Shibata Y; Fujii M; Suzuki A; Koizumi N; Kanada K; Yamada M; Watanabe Y
Pharm Dev Technol; 2014 Jun; 19(4):468-74. PubMed ID: 23682860
[TBL] [Abstract][Full Text] [Related]
19. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
Desai D; Kothari S; Huang M
Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
[TBL] [Abstract][Full Text] [Related]
20. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
Jójárt-Laczkovich O; Katona G; Aigner Z; Szabó-Révész P
Eur J Pharm Sci; 2016 Dec; 95():145-151. PubMed ID: 27496047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
